Therapeutic Applications of Transcranial Magnetic Stimulation 

Dr. Antonello Bonci

(Boca Raton Event Location)

Despite a lot of scientific as well as clinical progress, there is a tremendous need for novel, effective therapeutic interventions to improve symptoms and quality of life in neuropsychiatric conditions. Transcranial magnetic stimulation (TMS) has received increasing attention as it has shown promising therapeutic potential for several neuropsychiatric conditions. The main goal of this presentation is to highlight the history as well as the latest findings on how TMS protocols can significantly impact the quality of life, as well as improve behavioral response as well as cognitive abilities in individuals with anxiety, depression, addictions, and cognitive deficits, including Neuro-Covid-19.

Learning Objectives

1. Articulate no less than 3 neuropsychiatric conditions suitable for TMS applications. 
2. Describe recent historical updates on TMS technology that make it suitable for a wider range of issues
3. Describe the science behind TMS and how it changes the brain at the cellular level.
4. List at least 3 treatment resistant conditions that have been successfully treated with TMS.   

2.0 CEU Hours 

Dr. Antonello Bonci

Dr. Antonello Bonci is the President and Founder of GIA Miami. Before moving to GIA Miami, he served for nearly a decade at the National Institute of Health (NIH) as Scientific Director of the National Institute on Drug Abuse (NIDA) at the NIH. Before that, he was Professor-in-Residence in the Department of Neurology at the University of California, San Francisco (UCSF). Dr. Bonci is known worldwide for his pioneering studies on the long-term effects of stress and drug exposure on the brain.  Dr. Bonci has received numerous international awards, such as the D. Efron Award at the ACNP, the Jacob P. Waletzky Memorial Award at the Society for Neuroscience, and the Federation of European Neuroscience Societies/ENJ Research Award. He is a member of the National Academy of Medicine, the American Academy of Physicians, the American Neurological Association, the Dana Alliance for Brain Initiatives, and a Fellow of ACNP. 

 Proudly Sponsored by:

John Davis, President